Laurion Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-350,766
| Closed | -$15.7M | – | 255 |
|
|
2024
Q2 | $15.7M | Sell |
350,766
-279,416
| -44% | -$12.5M | 0.19% | 35 |
|
|
2024
Q1 | $29.5M | Buy |
630,182
+61,200
| +11% | +$2.86M | 0.25% | 37 |
|
|
2023
Q4 | $20.2M | Buy |
568,982
+222,345
| +64% | +$7.91M | 0.17% | 31 |
|
|
2023
Q3 | $10.3M | Buy |
+346,637
| New | +$10.3M | 0.06% | 59 |
|
|
2022
Q2 | – | Sell |
-79,952
| Closed | -$1.76M | – | 389 |
|
|
2022
Q1 | $1.76M | Buy |
+79,952
| New | +$1.76M | 0.02% | 116 |
|
|
2018
Q4 | – | Sell |
-117,700
| Closed | -$3.37M | – | 745 |
|
|
2018
Q3 | $3.37M | Buy |
+117,700
| New | +$3.37M | 0.03% | 165 |
|